- July 23, 2021Annovis Bio to Present New Data at 2021 Alzheimer’s Association International Conference
- July 20, 2021Annovis Bio Reports Positive Safety Data from its Phase 2 Alzheimer’s Study
- July 2, 2021Annovis Bio to Present Data at Alzheimer's Association International Conference 2021 Highlighting Positive Clinical Outcomes from Its Two Phase 2a Trials
- October 01, 2019Axonal Transport and Neurological Disease
- May 21, 2019How did the amyloid hypothesis go from promising to perilous in the search for Alzheimer’s treatments?
- April 30, 2019After amyloid failures, it’s time to take a new tack for treating Alzheimer’s
Back to Top